| http://www.w3.org/ns/prov#value | - Another embodiment of the present invention is a polypeptide as described above for treating and/or preventing and/or alleviating disorders susceptible to modulation by the delivery of an EGFR or IGF-IR antagonist to the upper respiratory tract and lung without inactivation.
|
